International Journal of Theranostics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Novel Formulation of Cannabinoid Analogues Treating DLBCL and MCL

Cell and gene therapies are seen as the next frontier in medicine as they have the potential to bring cures to patients that suffer from life-threatening diseases without many treatment options available to them. The idea that a patient’s own cells can be reprogrammed to replace or eliminate faulty genes or to attack cancer cells in a way that is not naturally possible is giving hope to many. In 2017, we have seen several approvals from these innovative medicines, Kymriah, Yescarta and Luxturna to name a few. However, a key challenge for all players and drug-makers in this field remains to be addressed: The cost of manufacturing is critically high due to the nature of these highly personalized medicines.

Special Features

Full Text


Track Your Manuscript

Media Partners